Hereditary angioedema (HAE) is a rare genetic disorder that causes episodes of severe swelling throughout your body. It is caused by abnormal immune responses. But unlike allergic swelling, HAE is not ...

Editor’s note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription. There's a lot of latest developments. You ...

Results from Phase 2 clinical studies, CHAPTER-1 and RAPIDe-1, provide evidence of viability of bradykinin B2 receptor antagonism in management ...

Angiotensin-converting enzyme inhibitors (ACEi) are the leading cause of drug-induced angioedema in the USA, with an ...

Hereditary angioedema is a rare genetic disease characterized by severe and unpredictable swelling attacks. NTLA-2002 is an in vivo gene-editing therapy that is based on clustered regularly ...

Possible differential diagnoses for hereditary angioedema (HAE) include acquired angioedema with low C1 inhibitor enzyme (AAE-C1-INH), angiotensin-converting enzyme (ACE) inhibitor-induced angioedema ...

The FDA awards Fast Track designation to BW-20805 for hereditary angioedema, a therapy designed to reduce attacks through PKK suppression.

A single dose of the CRISPR-based gene-editing therapy NTLA-2002 significantly reduced angioedema attacks compared with placebo in patients with hereditary angioedema, according to results from a ...

Staying active is an important component of a healthy lifestyle — it improves heart health, builds strength, and supports mental well-being. For people living with hereditary angioedema (HAE), a rare ...

Hereditary angioedema (HAE) causes severe soft-tissue swelling when C1 inhibitor (C1-INH) dysfunction increases bradykinin, and added inflammation can worsen episodes. Food triggers vary, but studies ...

Data include a concurrent assessment of results collected from PGI and AMRA instruments, insights into clinically meaningful changes in HAE attack symptoms, and support for hierarchical ranking of RAP ...